Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) FCF Payout Ratio (2021 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed FCF Payout Ratio for 5 consecutive years, with 0.01 as the latest value for Q3 2025.

  • Quarterly FCF Payout Ratio fell 99.44% to 0.01 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.01 through Dec 2025, down 75.46% year-over-year, with the annual reading at 0.01 for FY2025, 75.46% down from the prior year.
  • FCF Payout Ratio hit 0.01 in Q3 2025 for Ani Pharmaceuticals, up from 0.01 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 1.62 in Q3 2024 to a low of 0.09 in Q4 2022.
  • Historically, FCF Payout Ratio has averaged 0.11 across 5 years, with a median of 0.01 in 2025.
  • Biggest five-year swings in FCF Payout Ratio: tumbled 477.97% in 2022 and later soared 12072.0% in 2024.
  • Year by year, FCF Payout Ratio stood at 0.02 in 2021, then crashed by 477.97% to 0.09 in 2022, then soared by 109.09% to 0.01 in 2023, then surged by 74.82% to 0.01 in 2024, then crashed by 34.87% to 0.01 in 2025.
  • Business Quant data shows FCF Payout Ratio for ANIP at 0.01 in Q3 2025, 0.01 in Q2 2025, and 0.01 in Q1 2025.